Skip to content

HeRO® 00884450563922Recalls & reported problems

Merit Medical Systems, Inc. · Class 2 · Implant

All models of HeRO (12)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

The HeRO graft is an implanted vascular graft used to create dialysis access. Most of the 32 reports describe blood clots forming in the graft and problems at the access site, with patients needing procedures to open the graft, and some losing dialysis access entirely;30 injuries and 2 deaths were reported. No recalls name this device.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
36
Deaths reported
2
Injuries reported
33
Recalls naming it
0

Summary

The FDA's MAUDE database contains 36 adverse event reports that list this exact device (DI 00884450563922), received between Apr 11, 2024 and Sep 22, 2026 — classified as 2 deaths, 33 injuries, 1 malfunction.

The most frequently reported specific device problem is “Patient Device Interaction Problem” (4 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 9 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 16 reportsMay 2026: 3 reportsJun 2026: 2 reportsJul 2026: 2 reportsAug 2026: 1 reportsSep 2026: 2 reportsOct 2026: 0 reports20242025202616
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem26
  • Patient Device Interaction Problem4
  • Obstruction of Flow3
  • Connection Problem1
  • Degraded1
  • Disconnection1
  • Fluid/Blood Leak1
  • Material Erosion1

Patient problems

  • Thrombosis/Thrombus22
  • Unspecified Infection5
  • Stenosis3
  • Unintended Loss of Vascular Access3
  • Obstruction/Occlusion2
  • Abscess1
  • Hemorrhage/Blood Loss/Bleeding1
  • Infiltration into Tissue1

Recent adverse event reports

The 25 most recent of 36 reports, in the reporter's own words as published by the FDA.

  • InjurySep 22, 2026Adverse Event Without Identified Device or Use Problem

    The subject in a clinicial trial was experiencing a confirmed graft occlusion on (b)(6) 2026. Plan is to get blood pressure better controlled and then revise HERO as low blood pressure is suspected cause.

    Patient problems: Obstruction/Occlusion

    MAUDE report 50854143 ↗
  • InjurySep 9, 2026Adverse Event Without Identified Device or Use Problem

    The subject in a Merit HeRO graft clinicial trial experienced was seen at dialysis on (b)(6) 2026 no bruit/thrill. Seen in clinic (b)(6) 2026 with thrombosed Hero graft. Revision with thrombectomy (b)(6) 2026.

    Patient problems: Thrombosis/Thrombus; Unintended Loss of Vascular Access

    MAUDE report 50689687 ↗
  • MalfunctionAug 21, 2026Fluid/Blood Leak; Material Split, Cut or Torn

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50372812 ↗
  • InjuryJul 28, 2026Adverse Event Without Identified Device or Use Problem

    The subject in a Merit HeRO graft clinical trial experienced difficulty with dialysis on (b)(6) 2026 with infiltration and subsequent loss of thrill. Patient was seen in clinic and thrombosis verified. Patient had HERO revision and thrombectomy on (b)(6) 2026.

    Patient problems: Infiltration into Tissue; Thrombosis/Thrombus; Unintended Loss of Vascular Access

    MAUDE report 50052738 ↗
  • DeathJul 28, 2026Adverse Event Without Identified Device or Use Problem

    The subject in a Merit HeRO graft clinicial trial was admitted on (b)(6)2026 for acute on chronic hypoxic respiratory failure. On (b)(6)2026, a code was called for agonal breathing and profound bradycardia that became pulseless electrical activity (PEA) arrest. Cardiopulmonary resuscitation (CPR) was initiated on the patient resulting in intubation and transfer to the intensive care unit (ICU). Subject continued to experience profound bradycardia and PEA arrest despite several rounds of IV medications/fluids and the use of a LUCAS device. Subject coded multiple times for over a period of 5 hours. All efforts were eventually deemed futile and stopped. The patient expired.

    Patient problems: Respiratory Failure

    MAUDE report 50052736 ↗
  • InjuryJun 11, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICAL TRIAL EXPERIENCED THROMBOSIS OF HERO GRAFT. PATIENT REFERRED TO ACCESS CENTER. PATIENT HAD THROMBECTOMY AND ANGIOPLASTY PERFORMED TO CLEAR THROMBOSIS. PATIENT CAN USE GRAFT IMMEDIATELY.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 25472560 ↗
  • InjuryJun 11, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICAL TRIAL EXPERIENCED LOW FLOWS OF HERO GRAFT AT DIALYSIS AND WAS SENT TO ACCESS CENTER. PATIENT HAD ANGIOPLASTY OF DISTAL VENOUS GRAFT SEGMENT WITH GOOD RESULT. GRAFT IS READY FOR IMMEDIATE USE.

    Patient problems: Unintended Loss of Vascular Access

    MAUDE report 25472550 ↗
  • InjuryMay 13, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICAL TRIAL EXPERIENCED THE SYMPTOMS (PAIN, SWELLING, AND INABILITY TO CANNULATE) INDICATING AN ACCESS SITE COMPLICATIONS RESULTING IN LOSS OF FUNCTIONAL USE OF THE HERO IMPLANTED DEVICE AND NEED FOR ALTERNATIVE DIALYSIS ACCESS. THIS PATIENT HAD A HOSPITALIZATION AND PLACEMENT OF A TUNNELED DIALYSIS CATHETER (TDC). THE REQUIRED INTERVENTION WAS ON APRIL 14TH, 2026.

    Patient problems: Pain; Swelling/ Edema

    MAUDE report 25163787 ↗
  • InjuryMay 13, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICIAL TRIAL EXPERIENCED RECURRENCE OF THROMBOSIS OF THE HERO GRAFT, REQUIRING INTERVENTION TO MAINTAIN ACCESS PATENCY. THE REQUIRED INTERVENTION WAS ON (B)(6) 2026.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 25163778 ↗
  • InjuryMay 13, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICIAL TRIAL EXPERIENCED THROMBOSIS OF THE HERO GRAFT, REQUIRING INTERVENTION TO MAINTAIN ACCESS PATENCY. THE REQUIRED INTERVENTION WAS ON (B)(6) 2026.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 25163775 ↗
  • InjuryApr 30, 2026Adverse Event Without Identified Device or Use Problem

    ON (B)(6), 2026, INFORMATION WAS RECEIVED REGARDING A SUBJECT PARTICIPATING IN A CLINICAL TRIAL. THE SUBJECT EXPERIENCED THROMBOSIS REQUIRING MEDICAL INTERVENTION, INCLUDING THROMBECTOMY, ANGIOPLASTY, AND STENT PLACEMENT. THESE INTERVENTIONS WERE PERFORMED TO RESTORE ACCESS PATENCY. THE PATIENT OUTCOME FOLLOWING INTERVENTION WAS NOT REPORTED.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 25049000 ↗
  • InjuryApr 30, 2026Adverse Event Without Identified Device or Use Problem

    ON APRIL 15, 2026, INFORMATION WAS RECEIVED REGARDING A SUBJECT PARTICIPATING IN A CLINICAL TRIAL. THE SUBJECT EXPERIENCED COMPLICATIONS RELATED TO THE HERO GRAFT, SPECIFICALLY THROMBOSIS REQUIRING INTERVENTIONAL DECLOT PROCEDURES. DETAILS REGARDING THE SPECIFIC INTERVENTIONS AND PATIENT OUTCOME WERE NOT PROVIDED.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 25048095 ↗
  • InjuryApr 30, 2026Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2026, INFORMATION WAS RECEIVED REGARDING A SUBJECT PARTICIPATING IN A CLINICAL TRIAL. THE SUBJECT EXPERIENCED COMPLICATIONS RELATED TO THE HERO GRAFT, SPECIFICALLY THROMBOSIS REQUIRING INTERVENTIONAL DECLOT PROCEDURES. DETAILS REGARDING THE SPECIFIC INTERVENTIONS AND PATIENT OUTCOME WERE NOT PROVIDED.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 25048086 ↗
  • InjuryApr 30, 2026Adverse Event Without Identified Device or Use Problem

    ON APRIL 8, 2026, INFORMATION WAS RECEIVED REGARDING A SUBJECT PARTICIPATING IN A CLINICAL TRIAL. THE SUBJECT EXPERIENCED THROMBOSIS OF THE HERO GRAFT REQUIRING MEDICAL INTERVENTION, INCLUDING THROMBECTOMY AND ANGIOPLASTY. THE PATIENT OUTCOME FOLLOWING INTERVENTION WAS NOT FURTHER SPECIFIED.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 25048064 ↗
  • InjuryApr 30, 2026Adverse Event Without Identified Device or Use Problem

    ON APRIL 8, 2026, INFORMATION WAS RECEIVED REGARDING A SUBJECT PARTICIPATING IN A CLINICAL TRIAL. THE SUBJECT EXPERIENCED THROMBOSIS OF THE HERO GRAFT REQUIRING MEDICAL INTERVENTION, INCLUDING THROMBECTOMY AND ANGIOPLASTY. THE PATIENT OUTCOME FOLLOWING INTERVENTION WAS NOT FURTHER SPECIFIED.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 25048057 ↗
  • InjuryApr 30, 2026Adverse Event Without Identified Device or Use Problem

    ON APRIL 6, 2026, INFORMATION WAS RECEIVED REGARDING A SUBJECT PARTICIPATING IN A CLINICAL TRIAL. THE SUBJECT EXPERIENCED THROMBOSIS OF THE HERO GRAFT IN CONJUNCTION WITH IN-STENT STENOSIS. THE PATIENT OUTCOME WAS NOT REPORTED.

    Patient problems: Stenosis; Thrombosis/Thrombus

    MAUDE report 25048045 ↗
  • InjuryApr 30, 2026Adverse Event Without Identified Device or Use Problem

    ON APRIL 1, 2026, INFORMATION WAS RECEIVED REGARDING A SUBJECT PARTICIPATING IN A CLINICAL TRIAL. THE SUBJECT EXPERIENCED THROMBOSIS OF THE HERO GRAFT REQUIRING MEDICAL INTERVENTION, INCLUDING THROMBECTOMY AND ANGIOPLASTY, TO RESTORE PATENCY. THIS EVENT REPRESENTS A RECURRENT THROMBOSIS IN THE SAME SUBJECT, NECESSITATING REPEAT INTERVENTION. THE PATIENT OUTCOME FOLLOWING INTERVENTION WAS NOT FURTHER SPECIFIED.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 25048022 ↗
  • InjuryApr 17, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICAL TRIAL EXPERIENCED THROMBOSIS OF THE HERO GRAFT, REQUIRING INTERVENTION INCLUDING THROMBECTOMY AND ANGIOPLASTY TO RESTORE PATENCY.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 24914727 ↗
  • InjuryApr 17, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICIAL TRIAL EXPERIENCED A CLOTTED HERO GRAF ON (B)(6) 2026, AND THE PATIENT HAD A SUCCESSFUL DECLOT THE SAME DAY.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 24914684 ↗
  • InjuryApr 17, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICIAL TRIAL EXPERIENCED A CLOTTED HERO GRAFT ON 11JAN2026, AND THE PATIENT HAD AN ANGIOPLASTY PERFORMED ON (B)(6) 2026 WITH GOOD RESULTS.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 24914683 ↗
  • InjuryApr 17, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICIAL TRIAL EXPERIENCED IN-STENT RESTENOSIS WITH ASSOCIATED THROMBOSIS, REQUIRING PERCUTANEOUS INTERVENTION (ANGIOPLASTY) TO RESTORE PATENCY IN THE HERO GRAFT. PATIENT HAD ANGIOPLASTY TO OPEN UP IN-STENT STENOSIS SUCCESSFULLY.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 24914681 ↗
  • InjuryApr 17, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICIAL TRIAL WENT TO ACCESS CENTER ON (B)(6) 2026 AND HAD DECLOT WHICH INCLUDED A THROMBECTOMY, ANGIOPLASTY, AND STENT PLACEMENT TO STENOSIS. PROCEDURE WAS SUCCESSFUL.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 24914668 ↗
  • InjuryApr 17, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICIAL TRIAL EXPERIENCED A STENOSIST IN THE HERO GRAFT. PATIENT SENT TO ACCESS CENTER FOR DECLOT. DECLOT PERFORMED SUCCESSFULLY.

    Patient problems: Stenosis

    MAUDE report 24914667 ↗
  • InjuryApr 17, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICIAL TRIAL EXPERIENCED A CLOTTED HERO GRAFT ON (B)(6) 2026, AND THE PATIENT HAD A SUCCESSFUL DECLOT THE (B)(6) 2026 WITH HEMODIALYSIS PERFORMED AFTERWARDS.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 24914662 ↗
  • InjuryApr 17, 2026Adverse Event Without Identified Device or Use Problem

    THE SUBJECT IN A CLINICIAL TRIAL EXPERIENCED A THROMBUS IN THE HERO GRAFT, AND WAS SENT TO THE ACCESS CENTER FOR A DECLOT PROCEDURE. THE DECLOT WAS PERFORMED SUCCESSFULLY.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 24914652 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page